Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Adicet Bio Inc (ACET)

Adicet Bio Inc (ACET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 224,804
  • Shares Outstanding, K 31,842
  • Annual Sales, $ 17,900 K
  • Annual Income, $ -36,680 K
  • 60-Month Beta 2.42
  • Price/Sales 12.88
  • Price/Cash Flow N/A
  • Price/Book 1.11
Trade ACET with:

Options Overview

Details
  • Implied Volatility 71.42%
  • Historical Volatility 59.56%
  • IV Percentile 19%
  • IV Rank 2.94%
  • IV High 949.61% on 11/03/20
  • IV Low 44.86% on 04/09/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1
  • Open Int (30-Day) 25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.39
  • Prior Year -2.84
  • Growth Rate Est. (year over year) +86.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.25 +12.64%
on 08/20/21
8.58 -17.95%
on 09/02/21
-0.06 (-0.85%)
since 08/16/21
3-Month
6.25 +12.64%
on 08/20/21
10.66 -33.99%
on 06/21/21
-3.36 (-32.31%)
since 06/16/21
52-Week
6.25 +12.64%
on 08/20/21
21.40 -67.10%
on 09/18/20
-8.36 (-54.29%)
since 09/16/20

Most Recent Stories

More News
Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, and Twist Bioscience Corporation...

ACET : 7.04 (-0.28%)
TWST : 113.87 (+0.81%)
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Adicet Bio, Inc. (Nasdaq: ACET),...

TWST : 113.87 (+0.81%)
ACET : 7.04 (-0.28%)
Adicet Bio, Inc. (ACET) Reports Q2 Loss, Tops Revenue Estimates

Adicet Bio, Inc. (ACET) delivered earnings and revenue surprises of 33.33% and 6.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ACET : 7.04 (-0.28%)
Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today reported operational highlights...

ACET : 7.04 (-0.28%)
Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate...

ACET : 7.04 (-0.28%)
Adicet Bio Announces Formation of Scientific Advisory Board

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the formation of a Scientific...

ACET : 7.04 (-0.28%)
Adicet Bio Added to the Russell 2000(R) Index

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that the Company has been added...

ACET : 7.04 (-0.28%)
Moving Average Crossover Alert: Adicet Bio (ACET)

Adicet Bio (ACET) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

ACET : 7.04 (-0.28%)
New Strong Sell Stocks for May 28th

ACET, FURY, KRYS, MRSN, and NBEV have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2021

ACET : 7.04 (-0.28%)
NBEV : 1.4300 (unch)
KRYS : 56.49 (+0.77%)
MRSN : 9.71 (+7.89%)
FURY : 0.6862 (-1.97%)
Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that company management will participate...

ACET : 7.04 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.

See More

Key Turning Points

3rd Resistance Point 8.18
2nd Resistance Point 7.91
1st Resistance Point 7.48
Last Price 7.04
1st Support Level 6.78
2nd Support Level 6.51
3rd Support Level 6.08

See More

52-Week High 21.40
Fibonacci 61.8% 15.61
Fibonacci 50% 13.82
Fibonacci 38.2% 12.04
Last Price 7.04
52-Week Low 6.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar